Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$0.18 - $0.48 $610,952 - $1.63 Million
-3,394,179 Reduced 68.43%
1,565,869 $469,000
Q1 2023

May 12, 2023

SELL
$0.34 - $1.19 $116,996 - $409,488
-344,108 Reduced 6.49%
4,960,048 $2.13 Million
Q4 2022

Feb 13, 2023

BUY
$1.03 - $2.0 $1.57 Million - $3.05 Million
1,524,735 Added 40.34%
5,304,156 $6.26 Million
Q3 2022

Nov 14, 2022

BUY
$0.42 - $3.92 $947,347 - $8.84 Million
2,255,590 Added 148.02%
3,779,421 $8.77 Million
Q2 2022

Aug 12, 2022

BUY
N/A
665,044 Added 77.44%
1,523,831 $3.37 Million
Q1 2022

May 12, 2022

BUY
N/A
858,787 New
858,787 $8.27 Million

Others Institutions Holding GRNA

# of Institutions
1
Shares Held
51.5K
Call Options Held
0
Put Options Held
0

About GreenLight Biosciences Holdings, PBC


  • Ticker GRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 151,460,000
  • Description
  • GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in...
More about GRNA
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.